Canada, California and Congress: The Three C’s of New North American Regulatory Concern

Oct 24th, 2013

David C. Steinberg, Steinberg & Associates

“When I use a word,” Humpty Dumpty said, in rather a scornful tone, “it means just what I choose it to mean—nothing more and nothing less.”

Log in to view the full article

'We have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm.'

U.S. FDA, Congress to Write CBD its Own Rules for Food, Supplements

After careful review, the U.S. Food and Drug Administration (FDA) has concluded that a regulatory pathway specific to CBD, rather than CBD foods and supplements, is needed to balance CBD product demand with the potential risks.

If you have registered under the Voluntary Cosmetic Registration Program (VCRP), you may be covered for the initial registration. However, cosmetic product registrations must be updated annually. New products must be registered within 120 days of introduction into interstate commerce.

7 Implications of the Modernization Act for Cosmetics

President Biden signed HR 2617 into law. What does this mean for cosmetic manufacturers? "A lot," according to Steinberg & Associates. The 1,653-page bill includes 14 pages on cosmetics. Read on to learn more.

Circular beauty through upcycling

Circular beauty through upcycling

Thinking to start using upcycled ingredients but also need performance? How new innovative biobased company supports sustainability through upcycling.

The U.S. Hemp Roundtable said the FDA’s comments signal 'the new year may offer some promise for the long-awaited regulation of hemp-derived extracts such as CBD.'

FDA to Explore CBD, Hemp Regulations for Food and Supplements

The U.S. Food and Drug Administration (FDA) is exploring whether legal cannabis is safe in food or supplements and expects to make recommendations in the coming months for regulating such products. Could this translate to cosmetics?

The long-awaited legislation advances product safety and innovation for the science-driven beauty and personal care industry and reinforces consumer confidence, according to the PCPC.

U.S. House/Senate, President Biden Pass 2023 Consolidation Act; PCPC Applauds Cosmetic Inclusion

The long-awaited legislation will advance product safety and innovation for the science-driven beauty and personal care industry and reinforce consumer confidence, according to the Personal Care Products Council (PCPC).

This will make New York the 10th state to prohibit the sale of cosmetics tested on animals.

New York Cruelty Free Cosmetics Act Signed into Law

The legislation will go into effect as of Jan. 1, 2023, and will end the sale of cosmetics tested on animals in New York State, WBNG reports.

The guidelines include how consumers are likely to interpret particular claims and how marketers can substantiate these claims to avoid deceiving consumers.

Avoid Deceptive Eco Claims by Helping FTC Shape the Green Guides

The commission is seeking public comment to update the guidelines. This move is based on increasing consumer interest in buying environmentally friendly products.

'We extend our thanks to Congress for their efforts in this area and ask that leadership consider including cosmetics modernization in any end of year spending bill.'

Fragrance Creators Press U.S. Congress to Finalize Safe Cosmetics Act in 2022

As the year draws to an end, the association and allied trades are urging the U.S. Congress to come to a bipartisan, comprehensive and uniform national framework for cosmetics regulation.

To date, Adam’s Polishes has not received any reports of injury, illness or other adverse events related to this recall.

FDA Alert: Adam's Polishes Recalls Hand Sanitizers Over Methanol Concerns

The company is voluntarily recalling lot #133475 of Adam’s Polishes Hand Sanitizer after the U.S. Food and Drug Administration found this lot contain undeclared methanol; 19 other lots have been recalled to err on the side of caution.

In response to the FDA's proposed ten cent per pound fee increase, Dobos explains how the price has not been adjusted since 2005 and represents an approximately 30% increase.

Dobos Responds to U.S. FDA's Proposed Color Additive Fee Increase

Considering the U.S. Food and Drug Administration's (FDA's) proposed ten cent per pound fee increase on color additives, Dobos responds here noting that the price has not changed since 2005 but it also represents an approximately 30% increase.

Originally expected at the end of 2022, the revision to REACH is now set for the fourth quarter of next year.

EC Puts REACH Revisions On Hold Until Late 2023

On Oct. 18, 2022, the European Commission (EC) adopted working plans for 2023, which confirmed another delay of the long-awaited revision to REACH.